Luvixasertib hydrochloride (Standard)

Overview

Luvixasertib (hydrochloride) (Standard) is the analytical standard of Luvixasertib (hydrochloride) ( HY-101340A ). This product is intended for research and analytical applications. CFI-402257 hydrochloride is a highly selective and orally bioavailable TTK/Mps1 inhibitor with an IC50 of 1.7 nM for TTK in vitro. CFI-402257 hydrochloride has anti-cancer activity.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Others | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Mps1 | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-101340AR
• CAS No.: 1610677-37-6
• Molecular Formula: C28H31ClN6O3
• Molecular Weight: 535.04
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source